CLINICAL_TRIALS
research
· 2025-11-20
Clinical Trial Update: Rescue of Nephrons With ALE.F02 (RENAL-F02) [Phase 2]
Summary
This update reports that ALE.F02 (RENAL-F02) is in Phase 2 testing for rapidly progressive glomerulonephritis and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alentis Therapeutics AG | Conditions: Glomerulonephritis Rapidly Progressive | Phase 2 | Status: RECRUITING